EU Food Watchdog Sets Ultra-Low CBD Safety Limits
The European Food Safety Authority (EFSA) has established provisional safe consumption levels for hemp-derived CBD, signaling a major regulatory shift. This highly cautious approach, setting limits far below global averages, threatens to force widespread product reformulations and reshape Europe’s CBD industry into a strictly controlled, low-dose market.
The new provisional safe intake level is set at 0.0275 milligrams per kilogram of body weight per day, equating to roughly 2 mg daily for a 70 kg adult. This applies exclusively to food supplements containing CBD with a purity of 98% or higher.
This ultra-low threshold highlights a stark contrast between European regulators and other global health authorities regarding CBD safety.
| Region | Daily CBD Consumption Limit | Conditions |
|---|---|---|
| European Union (EFSA) | ~2 mg (0.0275 mg/kg) | For 98%+ purity; excludes under 25s and pregnant women |
| United Kingdom | 10 mg | Standard threshold |
| Canada | 200 mg | Maximum of 30 consecutive days |
In the EU, CBD is classified as a “novel food,” meaning it cannot be sold freely like everyday edibles and requires official scientific approval. This differs significantly from hemp seeds, which have a history of consumption and are not considered novel.
Since January 2023, the EU has enforced separate, specific limits for hemp-derived THC in food products made from hemp seeds.
| Hemp Seed Food Product | Maximum EU THC Limit |
|---|---|
| Dry Products (flour, protein, seeds) | 3 mg/kg |
| Hemp Seed Oil | 7.5 mg/kg |
These new CBD limits arrive after nearly three years of regulatory limbo. In 2022, the EFSA paused 19 applications from CBD companies, citing insufficient safety data regarding toxicity and long-term health effects. Even with the new provisional limits, the EFSA notes ongoing data gaps concerning CBD’s impact on the liver, nervous, endocrine, and reproductive systems.
The burden now falls on CBD manufacturers to provide the missing data to gain market approval. In 2025, the EFSA already rejected a synthetic CBD food supplement application due to inadequate safety evidence.
While a 2020 European Court of Justice ruling declared CBD is not a narcotic, the lack of full “novel food” authorization keeps edible CBD products in a grey area. However, topical creams and cosmetics containing CBD remain widely available, as they are governed by separate EU cosmetic regulations.
- 5 Things Experienced Consumers Look for When Choosing Premium Cannabis Flower - June 19, 2026
- How to Use CBD Roll-On Oil in Your Wellness Routine - June 19, 2026
- How Online Headshops Are Setting New Quality Standards for Legal Highs - June 19, 2026









